Register to get unlimited access to our investor forum and all editorial content, including our e-zine and weekly email. Registration is free and only takes a minute.
Top Story

Woodford Patient Capital plunges as Prothena trial fails

11 Comments Woodford Patient Capital plunges as Prothena trial fails

Prothena, one of the big biotech bets of fund manager Neil Woodford, has failed a key drugs test, wiping two thirds from its market value and souring third anniversary of his Woodford Patient Capital Trust.

E-ZINES
We’ve redesigned our e-zine to make it even easier to read with a new mobile version. Read the latest issue here